Wolverine Trading
NVS icon

Wolverine Trading’s Novartis NVS Stock Holding History

Wolverine Trading’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$548K Sell
4,415
-5,061
-53% -$618K ﹤0.01% 3607
2025
Q2 		$1.14M Buy
9,476
+1,522
+19% +$172K ﹤0.01% 2183
2025
Q1 		$895K Sell
7,954
-15,982
-67% -$1.7M ﹤0.01% 2348
2024
Q4 		$2.33M Buy
23,936
+15,928
+199% +$1.7M ﹤0.01% 1832
2024
Q3 		$926K Buy
+8,008
New +$909K ﹤0.01% 2426
2023
Q3 		– Sell
-8,823
Closed -$896K – 4911
2023
Q2 		$877K Sell
8,823
-1,306
-13% -$131K ﹤0.01% 2109
2023
Q1 		$928K Buy
+10,129
New +$885K ﹤0.01% 1955
2022
Q2 		– Sell
-6,800
Closed -$597K – 5342
2022
Q1 		$598K Sell
6,800
-17,844
-72% -$1.54M ﹤0.01% 3010
2021
Q4 		$2.15M Buy
+24,644
New +$2.05M ﹤0.01% 1816
2021
Q2 		– Sell
-2,453
Closed -$213K – 6487
2021
Q1 		$213K Buy
+2,453
New +$220K ﹤0.01% 4969
2020
Q3 		– Sell
-10,803
Closed -$943K – 4954
2020
Q2 		$943K Buy
10,803
+797
+8% +$68.8K ﹤0.01% 2059
2020
Q1 		$819K Sell
10,006
-4,968
-33% -$443K ﹤0.01% 2119
2019
Q4 		$1.42M Sell
14,974
-12,173
-45% -$1.09M ﹤0.01% 2106
2019
Q3 		$2.37M Sell
27,147
-27,565
-50% -$2.48M 0.01% 1318
2019
Q2 		$5M Buy
54,712
+46,202
+543% +$3.91M 0.01% 881
2019
Q1 		$733K Buy
8,510
+4,809
+130% +$386K ﹤0.01% 2366
2018
Q4 		$283K Sell
3,701
-670
-15% -$52.2K ﹤0.01% 3264
2018
Q3 		$337K Buy
+4,371
New +$323K ﹤0.01% 3607
2018
Q1 		– Sell
-3,809
Closed -$287K – 5615
2017
Q4 		$287K Buy
+3,809
New +$287K ﹤0.01% 3690
2016
Q4 		– Sell
-9,578
Closed -$621K – 4923
2016
Q3 		$680K Buy
9,578
+1,198
+14% +$87.3K ﹤0.01% 2271
2016
Q2 		$610K Buy
+8,380
New +$579K ﹤0.01% 2038

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's NVS Position: Q3 2025 in Review

Wolverine Trading reduced its Novartis (NVS) stake by 53% in Q3 2025, selling an estimated $618K and leaving 4,415 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.

Wolverine Trading first reported a position in NVS in Q2 2016 and has held it in 21 quarters since. The position peaked at $5M in Q2 2019. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Wolverine Trading held 4,415 shares of Novartis worth $548K as of Q3 2025.
  • Wolverine Trading sold 5,061 Novartis shares in Q3 2025, an estimated $618K.
  • Novartis made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3607 holding.
  • Wolverine Trading first reported a position in Novartis in Q2 2016 and has held it in 21 quarters since.
  • Wolverine Trading's Novartis position peaked at $5M in Q2 2019.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.